Lupin launched generic Vibra-Tabs® Tablet in the United States

Bookmark and Share

Lupin launched generic Vibra-Tabs® Tablet in the US

Reported by: Shikha Jain

Lupin Pharmaceuticals, Inc., has successfully launched Doxycycline Hyclate Tablet USP, 100
mg in United States dated 19 January 2018. The product is approved by USFDA on 11
September 2017. It is a generic equivalent of Pfizer Inc.’s Vibra-Tabs®, 100 mg, indicated for
treatment of several microbial infections and as an adjunctive therapy in certain acne.
According to IMS MAT November 2017, Doxycycline Hyclate Tablet USP, 100 mg had annual
sales of approximately USD 144 million in the US.

Click Here for more detail

Sponsors

register pay here for test series
Subscribe us
Scholarship by gpatindia
PHARMACIST TEST SERIES
TARGET GPAT 2015 TEST SERIES
JOIN GPAT TEST SERIES
Drug Inspector
PHARMACIST TEST SERIES
Submit details for seminars
Training programme
Clinical Research Institute
GPAT 2014
Admission alert
Advertise with us
PHARMA MBA INSTITUTES

MBA in Healthcare Management at Institute of Clinical Research (ICRI), Bangalore

Admission Open:Online  MBA in Healthcare Management 2017 at Institute of Clinical Research (ICRI), New Delhi, Bangalore, Mumbai, Pune  Embrace a successful career in healthcare Management with ICRI's Unique program ICRI is one of ...

PG Diploma in Healthcare & Hospital Management at ICRI, Jaipur and Bangalore

Admission open: PG Diploma in Healthcare & Hospital Management Our award-winning Post Graduate Diploma in Hospital Management programme was one of India’s first and till date the most sought-after programme within ...

Sponsors

Recent Posts

Tag Clouds

Tag Visitors Hits

29900756
Copy Protected by Tech Tips's CopyProtect Wordpress Blogs.